Eli Lilly’s Groundbreaking Alzheimer’s Treatment Receives FDA Approval: What Investors Need to Know
Eli Lilly’s new Alzheimer’s drug receives FDA approval, marking a major milestone in biotech. Discover investment insights and market impact for 2024.